StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
16
Publishing Date
2023 - 07 - 31
2
2023 - 07 - 27
1
2022 - 09 - 29
1
2022 - 02 - 25
1
2021 - 12 - 13
1
2021 - 12 - 06
1
2021 - 11 - 17
1
2021 - 11 - 15
1
2021 - 10 - 05
1
2021 - 09 - 09
1
2021 - 06 - 17
1
2021 - 04 - 13
1
2021 - 03 - 16
1
2021 - 03 - 10
1
2020 - 12 - 16
1
Sector
Health technology
16
Tags
Alliances
2
Als
3
Alzheimer
1
Alzheimer's
1
Alzheimer's disease
1
Alzheimer’s
1
Antibody
1
Application
2
Approval
4
Authorization
1
Bhv-7000
1
Bio-nc
1
Bioscience
2
Biotech-bay
1
Biotechnology
1
Business
5
Clinical-trials-phase-ii
2
Clinical-trials-phase-iii
2
Collaboration
4
Commercialization
2
Conference
2
Disease
3
Drug
3
Earnings
11
Enroll
5
Ev
4
Events
3
Fda
2
Financial
6
Financial results
10
Health
2
Label
2
License
4
Meeting
3
Mergers-and-acquisitions
2
Migraine
24
Money
2
Muscular atrophy
2
N/a
58
Nurtec
8
Offering
11
Pharm-country
16
Pharmaceutical
2
Phase 1
2
Phase 2
6
Phase 2/3
3
Phase 3
8
Platform
4
Positive
3
Presentation
5
Report
5
Research
5
Results
26
Therapeutics
3
Therapy
2
Topline
2
Topline results
2
Treatment
17
Trial
17
Update
2
Entities
Biohaven pharmaceutical holding company ltd.
16
Pfizer, inc.
1
Symbols
AMRN
14
AMRX
26
ANVS
16
APDN
36
ATNM
19
AVXL
12
BDX
20
BHVN
16
BMY
67
CERT
12
CTSO
12
CTXR
16
DGX
21
ECOR
19
FNCTF
22
HOTH
19
HSIC
14
ICPT
12
IMUX
15
INAB
17
INSM
21
ISEE
14
JNJ
70
KRMD
18
KRYS
12
LEGN
19
LLY
15
LUCD
17
MRK
47
MRNS
23
MS
15
NAOV
14
NRXP
21
ORMP
15
PAVM
17
PDSB
20
PFE
33
PTCT
14
PTPI
16
RCKT
15
REGN
13
RLYB
13
SCYX
12
SDGR
22
SEEL
18
SLS
16
SNGX
20
SNY
54
SNYNF
42
SONN
14
STIM
16
TEVA
19
TEVJF
18
TGTX
14
TNXP
31
TRVI
12
TRVN
16
URGN
25
VRPX
17
YMAB
22
Exchanges
Nyse
16
Crawled Date
2023 - 07 - 31
2
2023 - 07 - 27
1
2022 - 09 - 29
1
2022 - 02 - 25
1
2021 - 12 - 13
1
2021 - 12 - 06
1
2021 - 11 - 17
1
2021 - 11 - 15
1
2021 - 10 - 05
1
2021 - 09 - 09
1
2021 - 06 - 17
1
2021 - 04 - 13
1
2021 - 03 - 16
1
2021 - 03 - 10
1
2020 - 12 - 16
1
Crawled Time
08:00
1
12:00
2
12:15
1
13:00
2
13:20
1
13:30
1
14:00
1
14:30
1
15:00
2
16:00
2
22:03
1
23:00
1
Source
www.biospace.com
16
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Pharm-country
symbols :
Bhvn
save search
Biohaven's Taldefgrobep Alfa Receives EU Orphan Drug Designation for Spinal Muscular Atrophy
Published:
2023-07-31
(Crawled : 16:00)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
121.31%
|
O:
1.15%
H:
5.99%
C:
3.17%
drug
designation
Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments
Published:
2023-07-31
(Crawled : 16:00)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
121.31%
|
O:
1.15%
H:
5.99%
C:
3.17%
business
financial
results
Biohaven Provides Preliminary EEG Data Update for Kv7 Platform, Regulatory Update on Troriluzole and Other Corporate Updates
Published:
2023-07-27
(Crawled : 15:00)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
77.14%
|
O:
-17.35%
H:
2.49%
C:
-6.35%
update
Biohaven Provides Update From Pivotal Phase 2/3 Trial with Verdiperstat in Amyotrophic Lateral Sclerosis (Healy ALS Platform Trial)
Published:
2022-09-29
(Crawled : 13:20)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-72.25%
|
O:
-0.19%
H:
0.12%
C:
-0.07%
als
trial
update
sclerosis
platform
phase 2
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Published:
2022-02-25
(Crawled : 13:00)
- biospace.com/
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-44.65%
|
O:
-0.02%
H:
0.0%
C:
0.0%
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-68.49%
|
O:
-4.17%
H:
0.0%
C:
0.0%
treatment
migraine
positive
chmp
BIOHAVEN ANNOUNCES NURTEC® ODT RECEIVES FIRST GLOBAL APPROVAL OUTSIDE THE U.S. FOR PREVENTION OF MIGRAINE
Published:
2021-12-13
(Crawled : 13:00)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-58.63%
|
O:
-2.49%
H:
0.0%
C:
0.0%
nurtec
approval
migraine
Biohaven Names CEO Vlad Coric, MD, Chairman Of The Board Of Directors And Matthew Buten, Chief Financial Officer
Published:
2021-12-06
(Crawled : 13:30)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-61.29%
|
O:
-5.67%
H:
0.0%
C:
0.0%
ceo
NURTEC® ODT Approved In Kuwait For Acute Treatment Of Migraine
Published:
2021-11-17
(Crawled : 14:30)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-64.68%
|
O:
-0.75%
H:
0.0%
C:
0.0%
treatment
migraine
approval
Biohaven Completes Enrollment Of Verdiperstat Arm Of Pivotal Healey ALS Platform Trial Conducted By The Healey Center For ALS At Massachussetts General Hospital
Published:
2021-11-15
(Crawled : 15:00)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-65.44%
|
O:
0.93%
H:
0.0%
C:
-4.17%
platform
trial
als
enroll
Biohaven Announces Preliminary 3Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment
Published:
2021-10-05
(Crawled : 12:15)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-70.5%
|
O:
3.9%
H:
2.03%
C:
-3.89%
treatment
migraine
Biohaven Spotlights Nurtec® ODT (rimegepant), the only dual-therapy indicated for both the acute and preventive treatment of migraine, at the 2021 International Headache Society - European Headache Federation Joint Congress
Published:
2021-09-09
(Crawled : 12:00)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-68.0%
|
O:
-0.14%
H:
2.85%
C:
-0.58%
treatment
europe
migraine
therapy
Biohaven Appoints Kishen Mehta to Board of Directors
Published:
2021-06-17
(Crawled : 23:00)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-54.66%
|
O:
-0.11%
H:
2.38%
C:
1.5%
Biohaven Highlights Neuroscience Advancements with 22 Presentations at the 2021 American Academy of Neurology (AAN) Virtual Annual Meeting
Published:
2021-04-13
(Crawled : 12:00)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-40.43%
|
O:
0.0%
H:
3.32%
C:
2.84%
presentation
Biohaven Announces Pricing Of $200 Million Public Offering Of Common Shares - Mar 16, 2021
Published:
2021-03-16
(Crawled : 08:00)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-48.28%
|
O:
-4.75%
H:
3.68%
C:
-2.33%
offering
Biohaven's NURTEC® ODT Approved In Israel For Acute Treatment Of Migraine
Published:
2021-03-10
(Crawled : 22:03)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-47.72%
|
O:
1.54%
H:
0.95%
C:
-7.25%
israel
treatment
migraine
approval
Biohaven's Rimegepant For Preventive Treatment Of Migraine Published In The Lancet
Published:
2020-12-16
(Crawled : 14:00)
- biospace.com/
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
-52.45%
|
O:
1.4%
H:
1.19%
C:
-0.28%
treatment
lancet
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.